v3.26.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
CASH FLOWS FROM OPERATING ACTIVITIES        
Net loss $ (7,381,761) $ (7,795,322) $ (25,138,772) $ (13,141,353)
Adjustments to reconcile net loss to net cash flows from operating activities:        
Depreciation and amortization 149,358 178,313 323,868 361,674
Stock-based compensation expense     1,098,204 286,795
Loss on disposal of property and equipment     0 1,438
Change in inventory reserves 213,758 214,719 269,566 214,719
Amortization of right-of-use assets     116,737 92,791
Foreign currency exchange loss (gain) 683,434 (1,285,261) 281,024 (1,159,493)
Change in fair value of convertible notes (related party) (89,900) 3,590,600 8,172,700 3,895,000
Fair value change in warrants (96,398) 226,249 428,125 261,932
Changes in assets and liabilities        
Accounts receivable     (11,856) 93,266
Inventories     (1,232,167) (32,948)
Prepaid expenses and other assets     184,094 233,382
Accounts payable and other liabilities     484,261 4,581
Accrued expenses     (33,425) (235,893)
Lease liabilities     (156,023) (127,585)
Contract liabilities     (3,656) (25,237)
Net Cash Flows used in Operating Activities     (14,032,058) (9,118,664)
CASH FLOWS FROM INVESTING ACTIVITIES        
Purchases of property and equipment     (601,253) (236,685)
Purchases of marketable securities     (9,894,052) 0
Proceeds from maturity of marketable securities     24,249,439 0
Net Cash Flows provided by (used in) Investing Activities     13,754,134 (236,685)
CASH FLOWS FROM FINANCING ACTIVITIES        
Proceeds from issuance of common stock and restricted stock     43,422,613 44,139,201
Issuance costs of common stock and restricted stock     (1,838,508) (1,313,031)
Proceeds from exercise of options, net of expenses     0 192,260
Payments on financing obligation     0 (209,137)
Net Cash Flows provided by Financing Activities     41,584,105 42,809,293
Net change in cash and cash equivalents     41,306,181 33,453,944
Cash and cash equivalents - beginning of period     19,502,348 15,707,739
Effect of foreign currency exchange rate changes on cash and cash equivalents     (269,382) 1,182,054
Cash and cash equivalents - end of period 60,539,147 50,343,737 60,539,147 50,343,737
Supplemental cash flow disclosure        
Cash paid for interest     0 4,170
Noncash investing and financing activities        
Transfer from inventory to property and equipment     62,892 0
Property and equipment included in accounts payable     214,517 1,184
Operating lease right-of-use assets in exchange for operating lease liability     43,303 30,128
Fair value adjustment for liability-classified options and warrants exercised     0 293,143
Options Held [Member]        
Adjustments to reconcile net loss to net cash flows from operating activities:        
Change in fair value of option liabilities (199,536) 182,298 1,129,019 158,267
Derivative [Member]        
Adjustments to reconcile net loss to net cash flows from operating activities:        
Change in fair value of option liabilities $ 56,243 $ 0 $ 56,243 $ 0